Sinai Technologies Secures $10M in Seed Funding
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Stay updated with breaking news from Obvious Ventures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Miyoko’s Creamery Closes $52M Series C Funding Miyoko’s Creamery, a Petaluma, Calif.-based creator of vegan cheese and butter, raised $52M in Series C funding. The round was led by PowerPlant Partners, investing $40M in total, with participation from Cult Capital, Obvious Ventures, Stray Dog, and CPT Capital. The company will use the capital to continue to expand operations and its business reach, advancing both distribution and product innovation. Led by Miyoko Schinner, Founder and CEO, Miyoko’s Creamery creates cheese and butter based on actual plant milk, rather than oil and starc...
Octave, a San Francisco CA-based company which specializes in behavioral health, raised $20M in Series B funding. The round was led by Health Velocity Capital, and joined by Cigna Ventures as well as existing investors Greycroft, Obvious Ventures, Company Ventures and Felicis Ventures. The company plans to use the funding for technology and clinical innovation and expansion of business operations. Led by Sandeep Acharya, Co-Founder and CEO, Octave is a national behavioral health practice that provides care through in-person and virtual coaching, individual, relationship and group therapy. The...
Dyno Therapeutics, Inc., a Cambridge, Mass.-based biotechnology company applying artificial intelligence (AI) to gene therapy, raised $100m in Series A financing. The round was led by Andreessen Horowitz, with participation from a select syndicate of new investors including Casdin Capital, GV, Obvious Ventures and Lux Capital. Founding investors Polaris Partners, CRV and KdT Ventures all participated in the round. As part of the Series A financing, Jorge Conde, General Partner at Andreessen Horowitz, joined the company’s board of directors. Led by Eric Kelsic, PhD, founder and CEO, Dyno T...
MedCity News Andreessen Horowitz leads $100M Series A round in Dyno and its gene therapy tech Dyno Therapeutics’ technology for designing viral vectors that deliver gene therapies has led to partnerships with Novartis, Sarepta Therapeutics, and Roche. With the Series A financing, the startup plans to expand its technology to address more tissue types, and potentially add more partners. Shares0 Improved AAV vector capsid for gene therapy engineered with a new machine-guided approach shows, in red, improvements in efficiency of viral production based on the average effect of insertions at a...